Aprea Therapeutics Inc (NQ: APRE )
3.510
-0.240
(-6.40%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Aprea Therapeutics Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Aprea Therapeutics: Q4 Earnings Insights
March 26, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/pharma-lab-worker-ai_5.png?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 11, 2024
Via Benzinga
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/84e47459-b235-4270-a600-7d65179a7872/small/unknown-png.png)
![](https://ml.globenewswire.com/media/84e47459-b235-4270-a600-7d65179a7872/small/unknown-png.png)
Aprea Therapeutics to Present at DDR Inhibitors Summit 2024
January 30, 2024
From Aprea Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
A Look Into Healthcare Sector Value Stocks
October 30, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
5 Value Stocks To Watch In The Healthcare Sector
September 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
5 Value Stocks To Watch In The Healthcare Sector
September 04, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/4b5be207-2832-49b4-9e6a-15869e433e16/small/aprea-logo-445pt-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.